Clinical Trial Update: Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Vincristine with DOXIL and Dexamethasone versus Vincristine with Doxorubicin and Dexamethasone in newly diagnosed multiple myeloma has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Vincristine (vincristine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Multiple Myeloma, Myeloma | Phase 3 | Status: COMPLETED